再鼎医药(ZLAB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ZLAB 再鼎医药

已收盘 08-20 16:00:00 EDT

26.02

-0.70

-2.62%

盘后26.02

+0.000.00%

16:10 EDT

最高26.62	最低25.92	成交量138.61万
今开26.57	昨收26.72	日振幅2.62%
总市值29.23亿	流通市值23.84亿	总股本1.12亿
成交额3,624万	换手率1.51%	流通股本9,162万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ZLAB","market":"US","secType":"STK","nameCN":"再鼎医药","latestPrice":26.02,"timestamp":1787256000000,"preClose":26.72,"halted":0,"volume":1386065,"hourTrading":{"tag":"盘后","latestPrice":26.02,"preClose":26.02,"latestTime":"16:10 EDT","volume":2033,"amount":52898.37,"timestamp":1787256605122,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.026197604790419136,"floatShares":91619400,"shares":112353700,"eps":-1.702952,"marketStatus":"已收盘","change":-0.7,"latestTime":"08-20 16:00:00 EDT","open":26.57,"high":26.62,"low":25.92,"amount":36236919,"amplitude":0.026198,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.702952,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1787299200000},"marketStatusCode":5,"adr":1,"adrRate":10,"listingDate":1505880000000,"exchange":"NASDAQ","adjPreClose":26.72,"preHourTrading":{"tag":"盘前","latestPrice":26.42,"preClose":26.72,"latestTime":"09:27 EDT","volume":9168,"amount":241366.66944,"timestamp":1787232420053,"change":-0.3,"changeRate":-0.011228,"amplitude":0.02732},"postHourTrading":{"tag":"盘后","latestPrice":26.02,"preClose":26.02,"latestTime":"16:10 EDT","volume":2033,"amount":52898.37,"timestamp":1787256605122,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.990637,"impliedVol":0.6476,"impliedVolPercentile":0.51},"requestUrl":"/m/hq/s/ZLAB","defaultTab":"news","newsList":[{"id":"2660426681","title":"纳斯达克中国金龙指数涨超0.5%，金山云涨10.44%，再鼎医药涨6.59%，金生游乐涨6.30%，世纪互联涨4.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660426681","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660426681?lang=zh_cn&edition=full","pubTime":"2026-08-19 21:40","pubTimestamp":1787146850,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4563","BK4535","BK4531","BK4607","VNET","BK4548","BK4116","BK4608","BK4139","BK4585","KC","LU1046422090.SGD","ZLAB","BK4526","LU2488822045.USD","GDHG","BK4588","BK4216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660419415","title":"港股异动 | 再鼎医药(09688)早盘涨近7% argenx FcRn靶向药3期成功 再鼎拥有大中华区权益","url":"https://stock-news.laohu8.com/highlight/detail?id=2660419415","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660419415?lang=zh_cn&edition=full","pubTime":"2026-08-19 11:10","pubTimestamp":1787109029,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，再鼎医药(09688)早盘涨近7%，截至发稿，涨4.61%，报20.18港元，成交额1.31亿港元。消息面上，据药研网报道，8月17日，免疫学公司argenx宣布，核心产品FcRn拮抗剂(艾加莫德α)旗治疗成人自身免疫性肌炎的ALKIVIA 3期临床研究取得积极顶线结果。值得注意的是，argenx此前已将艾加莫德在大中华区的开发和商业化权益独家授予再鼎医药。值得注意的是，ALKIVIA研究本身是由argenx发起的3期全球研究，再鼎医药也参与了大中华区的临床开发和患者入组，若该适应症后续在全球获批，再鼎有望进一步拓展艾加莫德在中国自身免疫疾病领域的商业化版图。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1481781.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4548","BK4531","ZLAB","BK4585","BK1161","09688","KCAI","BK4526","BK4139","VXUS","BK1574","BK1588","LU2488822045.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658908597","title":"纳斯达克中国金龙指数跌超1%，中进医疗跌15.44%，网易跌4.33%，再鼎医药跌2.46%，新东方跌3.37%，中通跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2658908597","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658908597?lang=zh_cn&edition=full","pubTime":"2026-08-12 21:30","pubTimestamp":1786541426,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4085","IE00BMCWC346.EUR","LU1880383366.USD","LU1008478684.HKD","BK4509","ZJYL","LU1807302812.USD","BK4503","LU0359201612.USD","LU0426412945.USD","BK4588","LU0072913022.USD","LU0327786744.USD","BK4139","LU1043141123.HKD","BK4577","NERD","BK4082","ESPO","LU0426417589.USD","LU0880133367.SGD","ZLAB","LU1993786604.SGD","LU1228905540.USD","BK4563","LU0502904849.HKD","HERO","BK4501","LU1228905037.USD","LU0994945656.USD","LU1880383440.USD","LU0370786039.SGD","EDU","BK4531","IE00BVYPNQ40.USD","LU1152091168.USD","LU0823426308.USD","NTES","LU0545562505.USD","LU0048580855.USD","BK4204","BK4510","BK4514","BK4505","LU0067412154.USD","ODDS","IE00BYV24P56.USD","LU1152091754.HKD","LU0823426480.USD","LU1043141396.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658081928","title":"再鼎医药午前涨超5% 公司自主研发资产正逐步进入临床价值验证阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2658081928","media":"新浪港股","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658081928?lang=zh_cn&edition=full","pubTime":"2026-08-12 11:45","pubTimestamp":1786506300,"startTime":"0","endTime":"0","summary":"模拟交易客户端再鼎医药早盘一度涨超11%，绩后股价已累涨超三成。截至发稿，股价上涨5.13%，现报19.48港元，成交额3.59亿港元。再鼎医药今年二季度实现总收入为1.063亿美元，产品收入净额为1.058亿美元，环比增长11%，得益于则乐的稳定表现以及艾加莫德的销量持续增长。中信建投指出，公司自主研发资产正逐步进入临床价值验证阶段，核心自研管线有望于年内迎来密集数据读出及关键研发进展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-08-12/doc-inimzqcr3698280.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4526","LU2488822045.USD","BK4588","BK4531","ZLAB","BK1588","BK4585","BK4139","BK4548","09688","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658947545","title":"港股开盘 | 恒指低开0.6% 黄金股走强 再鼎医药(09688)涨超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658947545","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658947545?lang=zh_cn&edition=full","pubTime":"2026-08-12 09:29","pubTimestamp":1786498159,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，8月12日，恒生指数低开0.6%，报25498.39点；恒生科技指数跌0.8%，报4785.75点；国企指数跌0.57%，报8479.60点。大市盘前成交21.70亿港元。黄金股走强，紫金黄金国际涨超2%，中国黄金国际涨超2%，灵宝黄金涨超2%，老铺黄金涨近2%，山东黄金涨超1%。医药股走强，再鼎医药涨超8%，药明合联涨超1%。受再鼎医药隔夜美股涨超10%带动。受隔夜美股三大指数全线收跌、中概股金龙指数跌2.94%拖累，港股今日低开。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478792.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2488822045.USD","BK1588","ZLAB","BK1161","09688","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168242546","title":"港股开盘｜港股开盘持平；医药股走强；再鼎医药涨超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168242546","media":"港股开盘","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168242546?lang=zh_cn&edition=full","pubTime":"2026-08-12 09:21","pubTimestamp":1786497715,"startTime":"0","endTime":"0","summary":"盘面上，生物医药、资源金属及AI概念活跃，带动个股分化上行；在线娱乐、教育等消费服务类个股则出现回吐，市场风格短线偏向防御与结构性轮动。大型科技股延续弱势，多数回调逾0.5%，仅理想汽车小幅飘红；阿里、腾讯、京东等均低开，或受隔夜美股科技股走软及机构获利了结影响。盘面亮点集中在生物医药与资源股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09688","BK4588","VXUS","LU2488822045.USD","BK1161","BK1574","BK4526","BK4531","BK4548","BK1588","09939","BK1515","BK4585","ZLAB","KCAI","159938","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658915078","title":"再鼎医药(09688)授出购股权及受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2658915078","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658915078?lang=zh_cn&edition=full","pubTime":"2026-08-11 21:56","pubTimestamp":1786456598,"startTime":"0","endTime":"0","summary":"智通财经APP讯，再鼎医药(09688)发布公告，本公司于授出日期根据2024年股权激励计划授出1000份(以美国存托股份计)购股权、2600股(以美国存托股份计)受限制股份单位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478696.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4531","BK4588","09688","BK4585","BK4139","BK1588","BK1161","LU2488822045.USD","BK4548","BK4526","ZLAB","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658969219","title":"港股午评|恒生指数早盘跌0.63%    CRO概念继续走高","url":"https://stock-news.laohu8.com/highlight/detail?id=2658969219","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658969219?lang=zh_cn&edition=full","pubTime":"2026-08-11 12:00","pubTimestamp":1786420834,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，港股恒生指数跌0.63%，跌163点，报25773点；恒生科技指数跌1.27%。港股早盘成交1158亿港元。药明康德司法取得进展，有利于CXO公司在海外争取新的订单。再鼎医药涨超5%，Q2产品收入环比增长11%，花旗看好中国业务下半年企稳。津上机床中国涨超5%，电子与AI液冷两大领域在新订单占比约四成。黄金股普遍承压。油价走高加剧通胀上行担忧，美联储鹰派释放强硬信号。中国黄金国际跌2.5%；紫金矿业跌3.5%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478385.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1251922891.USD","LU1242518857.USD","LU0049853897.USD","LU2264538146.SGD","06616","LU1242518931.SGD","LU0348814723.USD","LU0328353924.USD","LU0173614495.USD","BK1191","LU0329678337.USD","LU2097828557.USD","300408","06821","LU0165289439.USD","LU0463099449.HKD","LU0572944931.SGD","BK1109","LU0326950275.SGD","BK1169","LU1224709979.USD","LU0634319403.HKD","LU0417516738.SGD","HSI","HK0000320264.USD","LU0345780521.USD","BK1544","LU0164865239.USD","HK0000306701.USD","LU1988902786.USD","BK1583","MCHmain","07200","09088","LU1188198961.HKD","LU0345780281.USD","BK1588","LU0588546209.SGD","LU0431992006.USD","LU1105468828.SGD","LU2460026573.USD","01548","LU0106252389.USD","02099","03033","BK1594","LU0509642566.USD","LU0269904917.USD","82800","ZIJMY","LU0561508036.HKD","LU1048596156.SGD","300759","LU0828238088.HKD","09067","LU0039217434.USD","LU0348825331.USD","LU1769817179.HKD","LU0082770016.USD","07552","LU0531971595.HKD","LU0918141887.USD","09688","688062","SG9999004220.SGD","LU0106959298.USD","LU0096374516.USD","LU1282648689.USD","02899","LU0797268264.HKD","LU2039709279.SGD","JINFF","07300","HSTECH","LU0181495838.USD","IE0032431581.USD","LU2097828714.EUR","HHImain","83115","BK1170","BK1574","LU0737861772.HKD","LU2399975544.HKD","ZLAB","03037","LU2097828805.USD","LU1808992512.USD","02837","01541","BK1576","LU0348816934.USD","LU1504937902.USD","03067","07226","PONY","LU0327786744.USD","LU0287142896.SGD","02631","LU0082770016.SGD","002821","03759","LU0266512473.USD","LU0737861699.HKD","06951","SG9999001093.SGD","LU1719994722.HKD","03417","03423","LU0149721374.USD","LU2097828474.EUR","SG9999003461.SGD","LU0329678170.USD","LU0540923850.HKD","03115","LU0417516902.SGD","LU0828237510.HKD","LU0918141705.HKD","LU0266512127.USD","LU1720050803.USD","BK1161","LU0307460666.USD","LU0228659784.USD","LU0048580855.USD","LU2008162690.USD","LU0274383008.USD","03088","LU0348767384.USD","LU0828237940.HKD","LU1769817096.USD","HK0000320223.HKD","LU1794554557.SGD","LU0348766576.USD","LU0043850808.USD","LU0821914370.USD","LU0348827113.USD","601899","LU0871576103.HKD","HK0000306685.HKD","LU2226246903.HKD","BK1129","BK1592","LU0244354667.USD","03032","09115","LU0348735423.USD","BK1190","LU0140636845.USD","02833","02800","BK1587","LU0278937759.USD","03419","LU0886674414.USD","BK1183","LU0469268626.HKD","LU3063872942.SGD","LU2488822045.USD","LU2097828631.EUR","BK1141","BK1198","02026","LU1303224171.USD","LU1961090484.USD","LU0620787316.HKD","LU0370786039.SGD","LU1770034418.SGD","688234","LU0061477393.USD","SG9999002463.SGD","02493","LU2177674079.SGD","LU0164939612.USD","LU0456854461.SGD","LU1831875114.USD","LU0211977185.USD","LU1481107354.HKD","LU0164880469.USD","513600","LU1064131342.USD","LU0868486357.SGD","07500","01651","BK1505","LU0979878070.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658966444","title":"港股异动 | 再鼎医药(09688)涨超7% Q2产品收入环比增长11% 花旗看好中国业务下半年企稳","url":"https://stock-news.laohu8.com/highlight/detail?id=2658966444","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658966444?lang=zh_cn&edition=full","pubTime":"2026-08-11 10:56","pubTimestamp":1786416987,"startTime":"0","endTime":"0","summary":"消息面上，再鼎医药近日公布2026年第二季度财务业绩以及近期产品亮点和公司进展。财报显示，2026年第二季度公司总收入为1.063亿美元，产品收入净额为1.058亿美元，环比增长11%，得益于则乐的稳定表现以及艾加莫德的销量持续增长。花旗发表报告指，再鼎医药第二季产品收入按季改善约11%至约1.06亿美元，符合该行和市场预期，令该行更有信心其中国业务可于2026年下半年企稳，并按管理层指引于2027年恢复显著增长。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478351.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BSNM7G36.USD","LU0130102774.USD","LU2456880835.USD","BK1161","BK4139","LU1201861249.SGD","BK4534","LU1244550577.SGD","LU0314106906.USD","TFNS","KCAI","LU0106831901.USD","BK4207","IYF","LU0648001328.SGD","LU1791807156.HKD","LU1074936037.SGD","BK4588","LU0980610538.SGD","LU1668664300.SGD","LU0128525689.USD","LU0477156953.USD","LU2462157665.USD","LU0162691827.USD","LU1244550494.USD","BK4526","09688","LU2360032135.SGD","LU0072461881.USD","LU1244550221.USD","BK4531","LU0320765646.SGD","FTXO","LU0203347892.USD","ZLAB","BK4559","BK1588","LU2417539215.USD","BK4585","LU1506573853.SGD","BK4548","VXUS","LU2125154778.USD","LU1366192091.USD","LU2125154935.USD","LU0130517989.USD","LU0170899867.USD","LU2488822045.USD","BK4504","LU1162221912.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658963017","title":"快讯：恒指高开0.24% 科指涨0.27% 黄金股普涨 AI应用股活跃","url":"https://stock-news.laohu8.com/highlight/detail?id=2658963017","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658963017?lang=zh_cn&edition=full","pubTime":"2026-08-11 09:20","pubTimestamp":1786411200,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端美股周一走势下滑，市场继续关注中东局势变化以及最新通胀数据表现，大市欠缺方向，三大指数均录得温和跌幅收市。美元反复向好，美国十年期债息上升至4.7厘水平，金价持续向上，油价亦表现向好。今日港股三大指数集体高开，恒指开盘涨0.24%，报25998.59点，恒科指涨0.27%，国企指数涨0.37%。盘面上，科网股涨跌不一，阿里巴巴涨超2%，小米跌近1%；AI应用股活跃，MINIMAX涨超4%；生物医药股高开，再鼎医药涨超4%；煤炭股多数上涨，中煤能源涨超1%；黄金股普涨，赤峰黄金涨超2%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-08-11/doc-inimwyqt7669414.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0328353924.USD","LU1267930227.SGD","LU2399975544.HKD","CLIX","BK1521","BK4533","KBAB","DRAG","LU0310800965.SGD","LU0052750758.USD","LU1515016050.SGD","BK4614","LU0821914370.USD","LU0588546209.SGD","LU0348825331.USD","BK1523","LU0449515922.USD","LU0880133367.SGD","02828","LU0072462343.USD","LU0164880469.USD","LU2039709279.SGD","LU2087589342.USD","LU2097828474.EUR","LU0231483743.USD","LU1868837565.USD","BK4524","IE00B0JY6N72.USD","IE00BF5LJ272.USD","BK1588","BK4527","LU0675040207.SGD","LU0823039010.USD","LU0128525689.USD","LU0531970944.HKD","IE00BFMHRM44.USD","BK4585","02837","LU1303224171.USD","LU0441854154.USD","LU1769817096.USD","BK4575","LU0359201885.HKD","LU0456827905.SGD","LU0106959298.USD","03423","DRGN","LU1808992512.USD","BK4558","07588","LU0979878070.USD","LU1051768304.USD","LU2778985437.USD","LU0047713382.USD","LU0823397285.USD","LU0823426308.USD","LU1880383440.USD","LU0143863784.USD","IE0032431581.USD","LU0326950275.SGD","LU0348814723.USD","IE0034224299.USD","LU0054450605.USD","LU2257852520.SGD","LU2148611432.USD","BABO","LU0456846285.SGD","LU0651946864.USD","LU0235996351.USD","BK1502","LU0084288322.USD","SG9999003461.SGD","HSI","BK4588","LU0449509016.USD","XIACY","03032","LU0320764599.SGD","LU1981816686.USD","LU0871576103.HKD","LU2294711473.HKD","09067","LU0918141887.USD","BBYY","LU0169518387.USD","ONLN","LU0700851271.USD","LU1769817179.HKD","LU0345775950.USD","LU0823038988.USD","LU0593848301.USD","BK4554","LU2488822045.USD","BK1506","LU0650527681.SGD","LU1323998911.USD","HSCEI","LU0214875030.USD","07552","BK1610","LU0348735423.USD","LU1152091168.USD","BK4526","LU0164865239.USD","LU1003077747.HKD","BK4538","LU0314109678.HKD","LU0823041008.USD","LU1813983027.USD","LU2152927971.USD","LU0051755006.USD","LU0651947912.USD","BK4531","BABU","BK1574","BK1575","LU0797268264.HKD","LU1048596156.SGD","LU0327786744.USD","LU0210526637.USD","LU0918141705.HKD","BK4587","LU0164872284.USD","LU1770034418.SGD","BK4504","BK4502","03088","LU1235294995.USD","LU0823426480.USD","LU1956131251.USD","LU0211977185.USD","BK4220","IE00B3M56506.USD","LU1282648689.USD","LU2476274308.USD","BK4543","LU0456842615.SGD","LU2097828557.USD","BK1615","BK1193","LU0738911758.USD","LU0307460666.USD","LU1046422090.SGD","BABW","MIUmain","HK0000286598.CNH","BK4505","09988","LU0417516738.SGD","03067","07226","BK1589","LU0572944931.SGD","LU1242518931.SGD","LU1823568750.SGD","LU1688375341.USD","LU0463099449.HKD","LU2097828714.EUR","ALBmain","BK4503","LU0117841782.USD","LU1023057109.AUD","LU2097828631.EUR","LU1051769294.HKD","LU1481107354.HKD","09088","BK4535","LU0067412154.USD","LU2097828805.USD","LU0634319403.HKD","LU0499858438.USD","LU0605514214.HKD","LU1961090484.USD","LU0561508036.HKD","03416","LU0143863198.USD","01810","BK4548","LU1794554557.SGD","LU0708995583.HKD","LU1152091754.HKD","LU0499858602.USD","HXXD.SI","LU0149721374.USD","LU0244354667.USD","LU1105468828.SGD","LU0348816934.USD","03417","BK4122","LU0531971595.HKD","LU0949170772.SGD","LU0348827113.USD","LU0823040885.USD","LU0611395673.USD","LU0661504455.SGD","LU0823413660.USD","LU0823413587.USD","LU1242518857.USD","SG9999002463.SGD","LU0359202008.SGD","BK4534","LU1880383366.USD","SG9999001093.SGD","09688","LU1719994722.HKD","LU1720050803.USD","BABA","07288","BK4581","HK0000165453.HKD","LU1046421795.USD","LU0052756011.USD","LU1770036033.HKD","LU0540923850.HKD","LU0594300179.USD","LU0594300419.USD","LU1048588211.SGD","LU0823397103.USD","LU0251143458.SGD","BK4607","LU1868838027.USD","LU0501845795.SGD","BK1607","81810","03033","LU1251922891.USD","LU0072913022.USD","BK1618","BK1161","LU0254981946.USD","LU1328277881.USD","LU0359201612.USD","LU0553294199.USD","LU0417516902.SGD","BK4565","BABX","LU0545039389.USD","LU2476274720.SGD","82828","LU0345776255.USD","LU1008478684.HKD","HSTECH","LU0039217434.USD","LU1188198961.HKD","ZLAB","LU2226246903.HKD","BK4579"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658673690","title":"再鼎医药(09688.HK)：2Q26业绩符合预期 关注ZOCI ESMO数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2658673690","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658673690?lang=zh_cn&edition=full","pubTime":"2026-08-09 01:17","pubTimestamp":1786209422,"startTime":"0","endTime":"0","summary":"　　公司公布2Q26 业绩：收入1.06 亿美元，同比下降3%；归母净亏损5,083 万美元，业绩符合我们预期。财务方面，2Q26 公司R&D费用6,177 万美元，同比增长22%，SG&A费用7,287 万美元，同比增长3%。　　考虑到则乐竞品集采以及艾加莫德价格承压，我们下调2026 年由亏损2.48 亿美元至亏损3.03 亿美元，下调2027 年由亏损2.55 亿美元至亏损3.11 亿美元。　　管线临床数据不及预期，商业化放量不及预期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260809/32329545.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["ZLAB","BK4139","BK4588","BK1588","BK1161","09688","BK4531","BK4526","LU2488822045.USD","BK4548","BK4585","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657641209","title":"美股异动 | 股价连续两日大涨！再鼎医药(ZLAB.US)涨逾10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657641209","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657641209?lang=zh_cn&edition=full","pubTime":"2026-08-07 22:06","pubTimestamp":1786111604,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","ZLAB","BK4548","BK4585","BK4531","BK4526","LU2488822045.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657202641","title":"美股异动 | 股价连续两日大涨！再鼎医药(ZLAB.US)涨逾10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657202641","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657202641?lang=zh_cn&edition=full","pubTime":"2026-08-07 22:06","pubTimestamp":1786111604,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，继昨日股价大涨逾13%之后，周五，再鼎医药(ZLAB.US)再度大涨逾10%，报23.03美元。消息面上，花旗发表报告称，再鼎医药二季度产品收入按季改善约11%至约1.06亿美元，符合该行和市场预期，令该行更有信心其中国业务可于2026年下半年企稳，并按管理层指引于2027年恢复显著增长。该行将再鼎医药美股目标价由44美元上调至45美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477594.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1588","BK4585","LU2488822045.USD","ZLAB","BK1161","BK4526","BK4548","BK4139","BK4588","BK4531","09688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657072649","title":"纳斯达克中国金龙指数涨超0.5%，嘉楠科技涨9.36%，大全新能源涨7.31%，禾赛科技涨6.20%，再鼎医药涨6.63","url":"https://stock-news.laohu8.com/highlight/detail?id=2657072649","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657072649?lang=zh_cn&edition=full","pubTime":"2026-08-07 21:40","pubTimestamp":1786110043,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2488822045.USD",".IXIC","BK4147","LU0390135332.USD","LU2476274308.USD","BK4585","BK4170","LU0390135688.USD","LU2476274720.SGD","BK4519","LU0229945570.USD","LU2778985437.USD","HSAI","NDX","CAN","BK4600","HXC","LU0300738514.USD","BK4588","BK4548","ZLAB","LU0300738605.USD","BK4139","BK4531","DQ","BK4526","02525","BK4124","LU0543330566.HKD","BK4131","BK4595","09688","LU0390135506.SGD","SFWL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657615812","title":"港股收评：恒指涨0.54% 科指涨0.78% PCB概念股强势 生物医药股大涨 智谱涨超14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657615812","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657615812?lang=zh_cn&edition=full","pubTime":"2026-08-07 16:08","pubTimestamp":1786090080,"startTime":"0","endTime":"0","summary":"截至收盘，恒生指数涨0.54%，恒生科技指数涨0.78%，国企指数涨0.39%。盘面上，科网股涨跌不一，联想涨超8%，哔哩哔哩跌超1%；PCB概念股强势，建滔积层板涨超9%；生物医药股大涨，再鼎医药涨超18%；AI应用股活跃，智谱涨超14%；拿森科技上市首日涨超64%。PCB概念股强势，建滔积层板涨超9%。生物医药股大涨，再鼎医药涨超18%。公开发售阶段拿森科技获2513.54倍认购，公开发售的发售股份最终数目为575.95万股股份，占发售股份总数的约10%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-08-07/doc-inimnrai3249015.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["03067","03419","09067","LU0672654166.SGD","HSTECH","09688","09115","LU1267930227.SGD","LU2929501877.USD","03088","07300","LU0049112450.USD","BK1193","LU0791591158.USD","MCHmain","LU0588546209.SGD","LU0310800965.SGD","LNVGY","06609","IE0003895053.USD","LU0384037296.USD","LU1328277881.USD","LU2097828557.USD","SG9999001069.SGD","HK0000306685.HKD","HK0000320264.USD","LU0791590937.USD","LU0128522157.USD","LU1282649810.SGD","LU2488822045.USD","07552","IE00B0JY6N72.USD","00992","09088","80992","LU2039709279.SGD","TCHI","LU0488056044.USD","02800","07226","03115","03033","LU0862451753.SGD","LU2097828474.EUR","ZLAB","BK1170","LU0370786039.SGD","09626","LU0314109678.HKD","BK1095","LU0862451837.USD","LU1282649067.USD","LU1282649141.HKD","LU1366334578.USD","LU0648948544.HKD","02513","BK1587","LU2187417386.USD","07200","LU0128525689.USD","SG9999003461.SGD","LU1235295612.USD","SG9999004220.SGD","BILI","BK1615","MCHS","LU1366334651.USD","HK0000306701.USD","IE0032431581.USD","LU0593848301.USD","82800","LU1813983027.USD","LU0211977185.USD","BK1117","LU1046422090.SGD","SG9999001051.SGD","07500","LU0029875118.USD","LU0320764755.SGD","IE0034224299.USD","LU2097828714.EUR","03423","LU0052756011.USD","02833","LU2097828631.EUR","03032","BK1608","BK1104","02837","BK1574","LU0264606111.USD","SG9999001093.SGD","LU0543330483.HKD","BK1161","BK1607","BK1526","LU1808992512.USD","01888","LU0307460666.USD","BK1588","LU2097828805.USD","LU1211504680.USD","LU0890818403.SGD","BK1575","03417","LU0572940350.SGD","FPA","HHImain","LU0274383008.USD","BK1100","HSI","LU2351347302.SGD","HK0000320223.HKD","LU0048580855.USD","BK1506","LU0572939691.SGD","03037","83115","LU2242644610.SGD","513600","SG9999006597.SGD","BK1618"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657434691","title":"再鼎医药（09688）午后涨16.1% 花旗料其中国业务可于下半年企稳","url":"https://stock-news.laohu8.com/highlight/detail?id=2657434691","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657434691?lang=zh_cn&edition=full","pubTime":"2026-08-07 13:53","pubTimestamp":1786081990,"startTime":"0","endTime":"0","summary":"金吾财讯 | 再鼎医药 开盘一路震荡走强午后继续高走，现价16.870港元，涨幅16.10%，花旗发表报告指，再鼎医药次季产品收入按季改善约11%至约1.06亿美元，符合该行和市场预期，令该行更有信心其中国业务可于2026年下半年企稳，并按管理层指引于2027年恢复显著增长。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/YjA5ZTU5M2U3ZjIyNGI4Mzk2MWM1NGUyNWZkZjFmMjE3MzEwNTIzMzcxNTY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YjA5ZTU5M2U3ZjIyNGI4Mzk2MWM1NGUyNWZkZjFmMjE3MzEwNTIzMzcxNTY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987735","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU0052756011.USD","IE00BSNM7G36.USD","BK4207","BK4526","LU1074936037.SGD","LU0320765646.SGD","LU0314106906.USD","BK4531","LU0310800965.SGD","BK1588","LU1791807156.HKD","BK4588","LU1162221912.USD","LU1201861249.SGD","LU2125154935.USD","ZLAB","LU0130517989.USD","LU1244550494.USD","09688","BK4504","LU0162691827.USD","IYF","LU1668664300.SGD","LU0203347892.USD","LU1366192091.USD","LU2360032135.SGD","BK1574","BK1161","LU0072461881.USD","FTXO","LU1244550221.USD","LU0477156953.USD","LU2417539215.USD","LU1244550577.SGD","LU2236285917.USD","BK4139","BK4559","LU0170899867.USD","LU0130102774.USD","LU0980610538.SGD","LU1267930227.SGD","LU0128525689.USD","LU0648001328.SGD","LU2488822045.USD","LU0098860793.USD","TFNS","BK4566","BK4585","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657943916","title":"再鼎医药披露2026年第二季度财务报告 推进多项在研项目进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2657943916","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657943916?lang=zh_cn&edition=full","pubTime":"2026-08-07 13:49","pubTimestamp":1786081740,"startTime":"0","endTime":"0","summary":"8月6日晚间，再鼎医药有限公司（以下简称“再鼎医药”）披露2026年第二季度财务报告。今年第二季度，再鼎医药实现总收入1.063亿美元，其中产品收入净额为1.058亿美元，环比增长11%；研发开支为6180万美元，经营亏损为7650万美元，净亏损为5080万美元。在发布财务数据的同时，再鼎医药还披露了多项在研产品进展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608073835092873.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608073835092873.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["ZLAB","BK1161","BK1574","09688","BK4585","LU2488822045.USD","BK1588","BK4526","BK4531","BK4139","BK4588","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657660793","title":"医药股强势走强 再鼎医药（09688）涨13.97%、药明生物（02269）涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657660793","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657660793?lang=zh_cn&edition=full","pubTime":"2026-08-07 10:06","pubTimestamp":1786068387,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药股强势走强，再鼎医药 涨13.97%，药明生物涨5.41%，药明合联涨4.78%，药明康德涨4.73%，百济神州涨3.66%，荣昌生物涨2.33%，泰格医药涨2.07%。。国信证券表示，2026年版国家基本药物目录近期正式发布，这是目录时隔8年再次进行系统调整。新版目录结合疾病谱变化和临床用药需求，进一步补充慢性病、儿童、专科疾病及中医药优势病种用药，并对剂型、规格进行优化，提升药品在不同人群和医疗场景中的适用性。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210810/Y2E2NzVmYjg0MWU1MjU0NDY3MDY2MjI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/Y2E2NzVmYjg0MWU1MjU0NDY3MDY2MjI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987694","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2045819591.USD","LU0348735423.USD","159938","KURE","LU0456846285.SGD","LU1303224171.USD","LU2488822045.USD","SG9999002562.SGD","LU2039709279.SGD","BK1515","BK4531","LU0327786744.USD","LU0588546209.SGD","BK4585","LU0348766576.USD","LU1794554557.SGD","LU0052750758.USD","LU0051755006.USD","LU0039217434.USD","09995","LU0326950275.SGD","LU0140636845.USD","LU0572944931.SGD","LU1880383366.USD","LU0516422440.USD","LU0516422952.EUR","LU0823426308.USD","LU2328871848.SGD","09939","ZLAB","06160","BK1589","LU0516423174.USD","LU2242644610.SGD","LU1770034418.SGD","LU0181495838.USD","LU0856984785.SGD","BK1574","02268","BK4526","LU0043850808.USD","09688","BK1583","02269","02359","03347","IE00B0JY6N72.USD","LU0348767384.USD","LU1720050803.USD","LU0359202008.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657660868","title":"港股异动 | 再鼎医药(09688)涨超13% 二季度产品收入环比增长11% 下半年将迎多管线催化剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2657660868","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657660868?lang=zh_cn&edition=full","pubTime":"2026-08-07 09:35","pubTimestamp":1786066550,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，再鼎医药涨超13%，截至发稿，涨12.11%，报16.29港元，成交额6970.39万港元。消息面上，8月6日晚，再鼎医药公布了2026年第二季度财务业绩以及近期产品亮点和公司进展。财报显示，2026年第二季度公司总收入为1.063亿美元，产品收入净额为1.058亿美元，环比增长11%，得益于则乐的稳定表现以及艾加莫德的销量持续增长。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477115.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09688","BK1574","VXUS","BK1161","LU2488822045.USD","BK4526","BK1588","BK4548","BK4588","ZLAB","KCAI","BK4139","BK4531","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657630228","title":"美股异动 | 再鼎医药(ZLAB.US)大涨逾12% Q2产品收入环比增长11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657630228","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657630228?lang=zh_cn&edition=full","pubTime":"2026-08-06 22:27","pubTimestamp":1786026476,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","ZLAB","BK4531","LU2488822045.USD","BK4548","BK4585","BK4588","BK4526"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zailaboratory.com","stockEarnings":[{"period":"1week","weight":0.0483},{"period":"1month","weight":0.3021},{"period":"3month","weight":0.399},{"period":"6month","weight":0.3333},{"period":"1year","weight":-0.246},{"period":"ytd","weight":0.5147}],"compareEarnings":[{"period":"1week","weight":-0.0044},{"period":"1month","weight":0.0363},{"period":"3month","weight":0.0355},{"period":"6month","weight":0.1155},{"period":"1year","weight":0.202},{"period":"ytd","weight":0.1278}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"再鼎医药有限公司是一家主要从事生物制药业务的控股公司。该公司致力于通过产品的发现、开发和商业化解决肿瘤、免疫、神经科学和感染性疾病领域未被满足的医疗需求。该公司拥有从发现阶段到临床项目后期的一系列专利候选药物，其中包括“则乐”、“OPTUNE”、“擎乐”、“纽再乐”及“卫伟迦”等。该公司在国内市场和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.085823},{"month":2,"riseRate":0.555556,"avgChangeRate":0.030708},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.076257},{"month":4,"riseRate":0.444444,"avgChangeRate":0.02394},{"month":5,"riseRate":0.444444,"avgChangeRate":0.004882},{"month":6,"riseRate":0.555556,"avgChangeRate":0.07528},{"month":7,"riseRate":0.444444,"avgChangeRate":0.000111},{"month":8,"riseRate":0.666667,"avgChangeRate":0.051968},{"month":9,"riseRate":0.375,"avgChangeRate":-0.055585},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.047464},{"month":11,"riseRate":0.555556,"avgChangeRate":0.101421},{"month":12,"riseRate":0.444444,"avgChangeRate":-0.029495}],"exchange":"NASDAQ","name":"再鼎医药","nameEN":"Zai Lab Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"再鼎医药(ZLAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供再鼎医药(ZLAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"再鼎医药,ZLAB,再鼎医药股票,再鼎医药股票老虎,再鼎医药股票老虎国际,再鼎医药行情,再鼎医药股票行情,再鼎医药股价,再鼎医药股市,再鼎医药股票价格,再鼎医药股票交易,再鼎医药股票购买,再鼎医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"再鼎医药(ZLAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供再鼎医药(ZLAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}